| Year |
Citation |
Score |
| 2023 |
Krug S, Gupta M, Kumar P, Feller L, Ihms EA, Kang BG, Srikrishna G, Dawson TM, Dawson VL, Bishai WR. Inhibition of host PARP1 contributes to the anti-inflammatory and antitubercular activity of pyrazinamide. Nature Communications. 14: 8161. PMID 38071218 DOI: 10.1038/s41467-023-43937-1 |
0.644 |
|
| 2023 |
Wazahat R, Juneja P, Chauhan V, Zaidi R, Lamichhane G, Singh UB, Haider M, Kumar P. A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria. Journal of Microbiological Methods. 211: 106781. PMID 37437716 DOI: 10.1016/j.mimet.2023.106781 |
0.737 |
|
| 2022 |
Ahmad N, Dugad S, Chauhan V, Ahmed S, Sharma K, Kachhap S, Zaidi R, Bishai WR, Lamichhane G, Kumar P. Allosteric cooperation in ß-lactam binding to a non-classical transpeptidase. Elife. 11. PMID 35475970 DOI: 10.7554/eLife.73055 |
0.753 |
|
| 2022 |
Galanis C, Maggioncalda EC, Kumar P, Lamichhane G. Glby, Encoded by , Is Required for Growth of Mycobacteroides abscessus and Exhibits Mild β-Lactamase Activity. Journal of Bacteriology. e0004622. PMID 35380462 DOI: 10.1128/jb.00046-22 |
0.715 |
|
| 2019 |
Saxena R, Stanley CB, Kumar P, Cuneo MJ, Patil D, Jha J, Weiss KL, Chattoraj DK, Crooke E. A nucleotide-dependent oligomerization of the Escherichia coli replication initiator DnaA requires residue His136 for remodeling of the chromosomal origin. Nucleic Acids Research. PMID 31665475 DOI: 10.1093/Nar/Gkz939 |
0.304 |
|
| 2019 |
Kumar P, Kumar A, Parveen S, Murphy JR, Bishai W. Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy. Immunotherapy. PMID 31361167 DOI: 10.2217/Imt-2019-0060 |
0.708 |
|
| 2019 |
Cheung LS, Fu J, Kumar P, Kumar A, Urbanowski ME, Ihms EA, Parveen S, Bullen CK, Patrick GJ, Harrison R, Murphy JR, Pardoll DM, Bishai WR. Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti-PD-1 in melanoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30718426 DOI: 10.1073/Pnas.1815087116 |
0.685 |
|
| 2017 |
Kumar P, Chauhan V, Silva JRA, Lameira J, d'Andrea F, Li S, Ginell SL, Freundlich JS, Alves CN, Bailey S, Cohen KA, Lamichhane G. Mycobacterium abscessus L,D-transpeptidases are susceptible to inactivation by carbapenems and cephalosporins but not penicillins. Antimicrobial Agents and Chemotherapy. PMID 28760902 DOI: 10.1128/Aac.00866-17 |
0.798 |
|
| 2017 |
Mattoo R, Lloyd EP, Kaushik A, Kumar P, Brunelle JL, Townsend CA, Lamichhane G. LdtMav2, a nonclassical transpeptidase and susceptibility of Mycobacterium avium to carbapenems. Future Microbiology. PMID 28555497 DOI: 10.2217/Fmb-2016-0208 |
0.758 |
|
| 2017 |
Bianchet MA, Pan YH, Basta LAB, Saavedra H, Lloyd EP, Kumar P, Mattoo R, Townsend CA, Lamichhane G. Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem. Bmc Biochemistry. 18: 8. PMID 28545389 DOI: 10.1186/S12858-017-0082-4 |
0.617 |
|
| 2017 |
Dey RJ, Dey B, Zheng Y, Cheung LS, Zhou J, Sayre D, Kumar P, Guo H, Lamichhane G, Sintim HO, Bishai WR. Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase. Nature Chemical Biology. 13: 210-217. PMID 28106876 DOI: 10.1038/Nchembio.2254 |
0.775 |
|
| 2017 |
Kumar P, Kaushik A, Bell D, Chauhan V, Xia F, Stevens RL, Lamichhane G. Mutation in an unannotated protein confers carbapenem resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. PMID 28069655 DOI: 10.1128/Aac.02234-16 |
0.774 |
|
| 2016 |
Kumar P, Kaushik A, Lloyd EP, Li SG, Mattoo R, Ammerman NC, Bell DT, Perryman AL, Zandi TA, Ekins S, Ginell SL, Townsend CA, Freundlich JS, Lamichhane G. Non-classical transpeptidases yield insight into new antibacterials. Nature Chemical Biology. PMID 27820797 DOI: 10.1038/Nchembio.2237 |
0.776 |
|
| 2015 |
Ekins S, Madrid PB, Sarker M, Li SG, Mittal N, Kumar P, Wang X, Stratton TP, Zimmerman M, Talcott C, Bourbon P, Travers M, Yadav M, Freundlich JS. Combining Metabolite-Based Pharmacophores with Bayesian Machine Learning Models for Mycobacterium tuberculosis Drug Discovery. Plos One. 10: e0141076. PMID 26517557 DOI: 10.1371/Journal.Pone.0141076 |
0.613 |
|
| 2015 |
Kumar P, Magala P, Geiger-Schuller KR, Majumdar A, Tolman JR, Wolberger C. Role of a non-canonical surface of Rad6 in ubiquitin conjugating activity. Nucleic Acids Research. PMID 26286193 DOI: 10.1093/Nar/Gkv845 |
0.725 |
|
| 2015 |
Kumar P, Wolberger C. Structure of the yeast Bre1 RING domain. Proteins. 83: 1185-90. PMID 25864391 DOI: 10.1002/Prot.24812 |
0.545 |
|
| 2013 |
Singh M, Kumar P, Yadav S, Gautam R, Sharma N, Karthikeyan S. The crystal structure reveals the molecular mechanism of bifunctional 3,4-dihydroxy-2-butanone 4-phosphate synthase/GTP cyclohydrolase II (Rv1415) from Mycobacterium tuberculosis. Acta Crystallographica. Section D, Biological Crystallography. 69: 1633-44. PMID 23999287 DOI: 10.1107/S0907444913011402 |
0.346 |
|
| 2011 |
Kumar P, Singh M, Karthikeyan S. Crystal structure analysis of icosahedral lumazine synthase from Salmonella typhimurium, an antibacterial drug target. Acta Crystallographica. Section D, Biological Crystallography. 67: 131-9. PMID 21245535 DOI: 10.1107/S0907444910053370 |
0.31 |
|
| 2010 |
Kumar P, Singh M, Gautam R, Karthikeyan S. Potential anti-bacterial drug target: structural characterization of 3,4-dihydroxy-2-butanone-4-phosphate synthase from Salmonella typhimurium LT2. Proteins. 78: 3292-303. PMID 20806221 DOI: 10.1002/Prot.22837 |
0.305 |
|
| Show low-probability matches. |
